Blood classical monocytes phenotype is not altered in primary non-small cell lung cancer

Table 1 Demographic details of lung cancer and non-cancer control subjects

	n	Age (yr)	Gender	Smoking status	Stages	Subtypes
		Mean ± SD	M/F	N/Ex/S	I/II/III/IV	N/A/S
Control	20	60.45 ± 19.31	10/10	7/11/2
Cancer	30	67.1 ± 10.68	17/13	3/16/11	8/3/7/12	9/11/10

Demographic details of the participants and staging details of lung cancer patients. This table shows the total number of patient samples, age, gender, smoking status and lung tumour subtypes and stages. n: Number; SD: Standard deviation; M: Male; F: Female; N: Non-smoker; Ex: Ex-smoker; S: Smoker; N: Non-small cell lung cancer; A: Lung adenocarcinoma; S: Squamous cell lung carcinoma.

Table 2 Complete blood count details of non-small cell lung cancer and non-cancer control patients

Groups	Total number	WBC	NE	LY	MO	EO	BA	RBC
Normal value		4-11 × 10-9/L	2-7.5 × 10-9/L	1.5-4 × 10-9/L	0.2-0.80 × 10-9/L	0.04-0.40 × 10-9/L	0.02-0.10 × 10-9/L	3.80-6.50 × 10-9/L
Control	20	4.35 ± 1.82	2.11 ± 1.07	1.31 ± 0.47	0.23 ± 0.14	0.13 ± 0.06	0.38 ± 0.5	4.85 ± 0.91
Cancer	30	6.76 ± 3.9	3.4095 ± 3.46	1.68 ± 1.31	0.34 ± 0.22	0.2 ± 0.17	0.29 ± 0.2	5.04 ± 1.08

Complete blood count (CBC) analysis of study participants. CBC analysis was performed on whole blood collected from patients with primary non-small cell lung cancer and non-cancer controls using Beckman Coulter (AcT 5 blood differentiation) (Fullerton, CA, United States). WBC: White blood cell; NE: Neutrophil; LY: Lymphocyte; MO: Monocyte; EO: Eosinophil; BA: Basophile; RBC: Red blood cell.